Ionis Pharmaceuticals, Inc.
COMPOUNDS AND METHODS FOR THE MODULATION OF AMYLOID-BETA PRECURSOR PROTEIN

Abstract:

Certain embodiments disclosed herein are directed to compounds and methods for modulating APP expression. In certain embodiments, modulating the splicing of amyloid precursor protein (APP) reduces amyloid .beta. (A.beta.) production.